Volume 32, Issue 2 pp. 200-204
Original Article
Free Access

Hepatocellular carcinoma occurring in nonfibrotic liver: Epidemiologic and histopathologic analysis of 80 French cases

Marie-Pierre Bralet M.D., Ph.D.

Corresponding Author

Marie-Pierre Bralet M.D., Ph.D.

d'Anatomie Pathologique, Clichy Cedex, France

Departement de Pathologie, Hôpital Henri Mondor, 51 avenue du Maréchal de Lattre de Tassigny, 94010 Créteil, Cedex, France.fax: (33) 1 49 81 27 33.===Search for more papers by this author
Jean-Marc Régimbeau

Jean-Marc Régimbeau

de Chirurgie Digestive et, Clichy Cedex, France

Search for more papers by this author
Pascal Pineau

Pascal Pineau

INSERM U163, Unité de Recombinaison et Expression Génétique, Institut Pasteur, Paris, France

Search for more papers by this author
Sylvie Dubois

Sylvie Dubois

d'Anatomie Pathologique, Clichy Cedex, France

Search for more papers by this author
Gwenolé Loas

Gwenolé Loas

CHU-Amiens, Amiens Cedex 1, France

Search for more papers by this author
Françoise Degos

Françoise Degos

d'Hépatologie, AP-HP, Hôpital Beaujon, Clichy Cedex, France

Search for more papers by this author
Dominique Valla

Dominique Valla

d'Hépatologie, AP-HP, Hôpital Beaujon, Clichy Cedex, France

Search for more papers by this author
Jacques Belghiti

Jacques Belghiti

de Chirurgie Digestive et, Clichy Cedex, France

Search for more papers by this author
Claude Degott

Claude Degott

d'Anatomie Pathologique, Clichy Cedex, France

Search for more papers by this author
Benoît Terris

Benoît Terris

d'Anatomie Pathologique, Clichy Cedex, France

Search for more papers by this author
First published: 30 December 2003
Citations: 175

Abstract

Hepatocellular carcinoma (HCC) occurring in nonfibrotic liver represents a rare, ill-defined subgroup of HCC without cirrhosis in which mechanisms of hepatocarcinogenesis remain unclear. The aim of our study was to assess epidemiological factors and detailed histopathologic changes in the nontumoral liver of patients developing such tumors. Of 330 HCCs resected in our institution between 1985 and 1998, we retrospectively analyzed 80 cases (53 men, 27 women; mean age, 51 ± 16 years) in which the nontumoral liver showed no (n = 28) or minimal (n = 52) portal fibrosis without any septal fibrosis. In the group with no portal fibrosis there was no male predominance, and patients were significantly younger (44 ± 19 years vs. 54 ± 14 years) than those with minimal portal fibrosis. Sixty-seven tumors were typical HCCs, 8 were of fibrolamellar type, and 5 were hepatocholangiocarcinomas. Mean tumor size was 10 ± 5 cm. Risk factors for HCC development were found in 30 patients: hepatitis B (n = 17) or C (n = 2) virus infections, alcohol consumption (n = 11), and hemochromatosis (n = 1). In the nontumoral liver, periportal and lobular necrosis, mild portal inflammation, steatosis, and iron overload were present in 15%, 57%, 52%, and 54% of cases, respectively. Liver cell changes were noted in 6%. This study emphasizes the need for strict criteria to classify HCC without cirrhosis. HCC in nonfibrotic liver is a distinct subgroup in which nontumoral liver shows nonspecific minimal changes without regeneration or premalignant lesion. Etiologic factors are often unidentified, although presence of HBV infection in 21% suggests a direct oncogenic role of this virus.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.